Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Molecular and genetic regulation of myelin capacity in the CNS

Award Number: R01NS138188
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/19/2025
PERIOD OF PERFORMANCE END DATE: 03/31/2030

Group Awards By:

View Award Description

Molecular and genetic regulation of myelin capacity in the CNS - PROJECT SUMMARY The myelin sheath is a multilayered membrane generated by specialized glial cells called oligodendrocytes (OLs) that iteratively spiral their plasma membranes around axon segments in the central nervous system (CNS) of vertebrates. Myelination serves to increase the conduction velocity of action potentials, and OLs provide trophic support that is vital for neuronal survival. The importance of myelin in human health is underscored in diseases in which it is disrupted, like leukodystrophies and multiple sclerosis. Despite the importance of myelin, we lack a complete understanding of the molecular and genetic mechanisms that govern OL development and myelination; additionally therapeutic strategies to promote remyelination are sorely lacking. This proposal focuses on two critical regulators of OL development and myelination: Fbxw7 and Myrf. Loss of Fbxw7, a ubiquitin ligase component, in animal models leads to increased amounts of myelin formation, whereas loss of Myrf results in a lack of myelination. Fbxw7 targets Myrf for degradation, and we hypothesize that Fbxw7 functions to limit myelination in the CNS by acting, at least in part, by controlling Myrf levels. In this proposal, we will employ a synergistic combination of zebrafish and mouse models to: 1) define the cellular mechanisms by which Fbxw7 regulates OL development, myelination, and myelin homeostasis; 2) determine the role of Fbxw7 in remyelination; 3) Define the cadre of myelin-promoting Fbxw7 targets in OLs, with a particular focus on Fbxw7’s regulation of Myrf. These experiments will enhance our understanding of OL biology and may lay the foundation for future therapeutics that stimulate myelin repair in humans.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $576,142 )
2026	2026	OREGON HEALTH & SCIENCE UNIVERSITY	3181 SW SAM JACKSON PARK RD	PORTLAND	OR	97239	MULTNOMAH	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	3/24/2026	NON-COMPETING CONTINUATION	$576,142
														Subtotal = $576,142

Issue Date FY: 2025 ( Subtotal = $576,142 )
2025	2025	OREGON HEALTH & SCIENCE UNIVERSITY	3181 SW SAM JACKSON PARK RD	PORTLAND	OR	97239	MULTNOMAH	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	6/19/2025	NEW	$576,142
														Subtotal = $576,142

Grand Total All Awards = $1,152,284

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Molecular and genetic regulation of myelin capacity in the CNS

Award Number: R01NS138188

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/19/2025

PERIOD OF PERFORMANCE END DATE: 03/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer